Abstract
Purpose. Amyloid-β (Aβ) is a self-aggregating protein found in senile plaques in Alzheimer's disease (AD) brain and is thought to play a major role in the disease process. Oxidative stress may be a predominant cause of the formation of these Aβ aggregates. This study aims at identifying possible sites of copper-catalyzed oxidation of Aβ1-40 using liquid chromatography tandem mass spectrometry (LC/MS/MS) and scoring algorithm for spectral analysis (SALSA). Traditionally, identification of post-translational modifications by tandem mass spectrometric analysis requires users to inspect manually thousands of MS/MS spectra, which can be a tedious and time-consuming process. With the use of SALSA, users can automatically search for post-translational modifications based on the spacing of the m/z values associated with the ion series of an amino acid sequence.
Methods. Aβ1-40 was subjected to copper-catalyzed oxidative stress. LC/MS/MS and SALSA analyses were used to determine the sites of post-translational modification within the tryptic fragments.
Results. Oxidation was found to occur preferentially at the histidine residues His13 and His14 and at the methionine residue (Met35) of Aβ1-40.
Conclusions. The combination of LC/MS/MS and SALSA searches could dramatically improve the efficiency and accuracy of determining the specific sites of oxidation of in vitro, copper-oxidized Aβ1-40 as well as other oxidized proteins.
Similar content being viewed by others
References
J. Hardy and D. J. Selkoe. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297:353-356 (2002).
T. Wisniewski, J. Ghiso, and B. Frangione. Biology of A beta amyloid in Alzheimer's disease. Neurobiol. Dis. 4:313-328 (1997).
C. Soto, M. C. Branes, J. Alvarez, and N. C. Inestrosa. Structural determinants of the Alzheimer's amyloid beta-peptide. J. Neurochem. 63:1191-1198 (1994).
F. Prelli, E. Castano, G. G. Glenner, and B. Frangione. Differences between vascular and plaque core amyloid in Alzheimer's disease. J. Neurochem. 51:648-651 (1988).
Y. Christen. Oxidative stress and Alzheimer disease. Am. J. Clin. Nutr. 71:621S-629S (2000).
W. R. Markesbery. Oxidative stress hypothesis in Alzheimer's disease. Free Radic. Biol. Med. 23:134-147 (1997).
M. A. Smith, C. A. Rottkamp, A. Nunomura, A. K. Raina, and G. Perry. Oxidative stress in Alzheimer's disease. Biochim. Biophys. Acta 1502:139-144 (2000).
M. Y. Aksenov, M. V. Aksenova, D. A. Butterfield, J. W. Geddes, and W. R. Markesbery. Protein oxidation in the brain in Alzheimer's disease. Neuroscience 103:373-383 (2001).
D. A. Butterfield, A. Castegna, and C. M. Lauderback. and J. Drake. Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death. Neurobiol. Aging 23:655-664 (2002).
J. T. Coyle and P. Puttfarcken. Oxidative stress, glutamate, and neurodegenerative disorders. Science 262:689-695 (1993).
C. W. Olanow. A radical hypothesis for neurodegeneration. Trends Neurosci. 16:439-444 (1993).
D. Dexter, C. Carter, F. Agid, Y. Agid, A. J. Lees, P. Jenner, and C. D. Marsden. Lipid peroxidation as cause of nigral cell death in Parkinson's disease. Lancet 2:639-640 (1986).
D. T. Dexter, C. J. Carter, F. R. Wells, F. Javoy-Agid, Y. Agid, A. Lees, P. Jenner, and C. D. Marsden. Basal lipid peroxidation in substantia nigra is increased in Parkinson's disease. J. Neurochem. 52:381-389 (1989).
B. S. Mandavilli, J. H. Santos, and B. Van Houten. Mitochondrial DNA repair and aging. Mutat. Res. 509:127-151 (2002).
R. Kohen and A. Nyska. Oxidation of biological systems: oxidative stress phenomena, antioxidants, redox reactions, and methods for their quantification. Toxicol. Pathol. 30:620-650 (2002).
M. A. Lovell, J. D. Robertson, W. J. Teesdale, J. L. Campbell, and W. R. Markesbery. Copper, iron and zinc in Alzheimer's disease senile plaques. J. Neurol. Sci. 158:47-52 (1998).
X. Huang, C. S. Atwood, M. A. Hartshorn, G. Multhaup, L. E. Goldstein, R. C. Scarpa, M. P. Cuajungco, D. N. Gray, J. Lim, R. D. Moir, R. E. Tanzi, and A. I. Bush. The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. Biochemistry 38:7609-7616 (1999).
X. Huang, M. P. Cuajungco, C. S. Atwood, M. A. Hartshorn, J. D. Tyndall, G. R. Hanson, K. C. Stokes, M. Leopold, G. Multhaup, L. E. Goldstein, R. C. Scarpa, A. J. Saunders, J. Lim, R. D. Moir, C. Glabe, E. F. Bowden, C. L. Masters, D. P. Fairlie, R. E. Tanzi, and A. I. Bush. Cu(II) potentiation of alzheimer abeta neurotoxicity. Correlation with cell-free hydrogen peroxide production and metal reduction. J.Biol. Chem. 274:37111-37116 (1999).
C. S. Atwood, R. D. Moir, X. Huang, R. C. Scarpa, N. M. Bacarra, D. M. Romano, M. A. Hartshorn, R. E. Tanzi, and A. I. Bush. Dramatic aggregation of Alzheimer abeta by Cu(II) is induced by conditions representing physiological acidosis. J. Biol. Chem. 273:12817-12826 (1998).
C. M. Yates, J. Butterworth, M. C. Tennant, and A. Gordon. Enzyme activities in relation to pH and lactate in postmortem brain in Alzheimer-type and other dementias. J. Neurochem. 55:1624-1630 (1990).
C. Schoneich and T. D. Williams. Cu(II)-catalyzed oxidation of beta-amyloid peptide targets His13 and His14 over His6: Detection of 2-Oxo-histidine by HPLC-MS/MS. Chem. Res. Toxicol. 15:717-722 (2002).
J. Lim and R. W. Vachet. Development of a methodology based on metal-catalyzed oxidation reactions and mass spectrometry to determine the metal binding sites in copper metalloproteins. Anal. Chem. 75:1164-1172 (2003).
D. C. Liebler, B. T. Hansen, S. W. Davey, L. Tiscareno, and D. E. Mason. Peptide sequence motif analysis of tandem MS data with the SALSA algorithm. Anal. Chem. 74:203-210 (2002).
B. T. Hansen, J. A. Jones, D. E. Mason, and D. C. Liebler. SALSA: a pattern recognition algorithm to detect electrophile-adducted peptides by automated evaluation of CID spectra in LC-MS-MS analyses. Anal. Chem. 73:1676-1683 (2001).
D. Burdick, B. Soreghan, M. Kwon, J. Kosmoski, M. Knauer, A. Henschen, J. Yates, C. Cotman, and C. Glabe. Assembly and aggregation properties of synthetic Alzheimer's A4/beta amyloid peptide analogs. J. Biol. Chem. 267:546-554 (1992).
E. Shacter. Quantification and significance of protein oxidation in biological samples. Drug Metab. Rev. 32:307-326 (2000).
J. Peng and S. P. Gygi. Proteomics: the move to mixtures. J. Mass Spectrom. 36:1083-1091 (2001).
W. Vogt. Oxidation of methionyl residues in proteins: tools, targets, and reversal. Free Radic. Biol. Med. 18:93-105 (1995).
A. Ducret and O. Van, I, J. K. Eng, J. R. Yates, III, and R. Aebersold. High throughput protein characterization by automated reverse-phase chromatography/electrospray tandem mass spectrometry. Protein Sci. 7:706-719 (1998).
J. R. Yates Iii. Database searching using mass spectrometry data. Electrophoresis 19:893-900 (1998).
D. N. Perkins, D. J. Pappin, D. M. Creasy, and J. S. Cottrell. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 20:3551-3567 (1999).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Schiewe, A.J., Margol, L., Soreghan, B.A. et al. Rapid Characterization of Amyloid-β Side-Chain Oxidation by Tandem Mass Spectrometry and the Scoring Algorithm for Spectral Analysis. Pharm Res 21, 1094–1102 (2004). https://doi.org/10.1023/B:PHAM.0000032994.36343.02
Issue Date:
DOI: https://doi.org/10.1023/B:PHAM.0000032994.36343.02